M. Vernaleone
Papers
1
Total Citations
17
H-Index
1
About
Dr. M. Vernaleone is a leading figure in the field of radiation oncology, with a specialized focus on stereotactic body radiotherapy (SBRT) for the treatment of oligometastatic disease. Their most impactful work centers on the application of robotic stereotactic radiotherapy for liver oligometastases originating from colorectal cancer, a challenging clinical scenario where precision is paramount. In their landmark 2019 study, "Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience," which has garnered 17 citations, Dr. Vernaleone demonstrated the feasibility and efficacy of this advanced technique, contributing critical evidence to the growing body of literature supporting SBRT as a non-invasive alternative to surgery. This work has helped refine patient selection criteria and treatment protocols, directly influencing clinical practice in managing metastatic colorectal cancer. By showcasing high local control rates with minimal toxicity, Dr. Vernaleone’s research underscores the potential of robotic radiosurgery to improve outcomes in carefully selected patients, solidifying their reputation as a key contributor to the evolution of precision radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1